News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,922 Results
Type
Article (39065)
Company Profile (279)
Press Release (646578)
Section
Business (203870)
Career Advice (1991)
Deals (35364)
Drug Delivery (86)
Drug Development (80807)
Employer Resources (168)
FDA (16090)
Job Trends (14805)
News (344560)
Policy (32439)
Tag
Academia (2530)
Alliances (49097)
Alzheimer's disease (1235)
Approvals (16024)
Artificial intelligence (133)
Bankruptcy (352)
Best Places to Work (11543)
Biotechnology (200)
Breast cancer (129)
Cancer (1118)
Cardiovascular disease (101)
Career advice (1660)
Cell therapy (238)
Clinical research (64295)
Collaboration (398)
Compensation (202)
COVID-19 (2532)
C-suite (96)
Data (1147)
Diabetes (154)
Diagnostics (6143)
Earnings (84832)
Employer resources (146)
Events (109609)
Executive appointments (317)
FDA (16640)
Funding (359)
Gene therapy (178)
GLP-1 (579)
Government (4326)
Healthcare (18680)
Infectious disease (2617)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16304)
Job creations (3624)
Job search strategy (1417)
Layoffs (413)
Legal (7853)
Lung cancer (171)
Manufacturing (178)
Medical device (13178)
Medtech (13183)
Mergers & acquisitions (19147)
Metabolic disorders (406)
Neuroscience (1516)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1503)
Obesity (234)
Opinion (179)
Patents (105)
People (56291)
Phase I (19968)
Phase II (28320)
Phase III (21116)
Pipeline (464)
Postmarket research (2554)
Preclinical (8501)
Radiopharmaceuticals (236)
Rare diseases (223)
Real estate (5890)
Regulatory (21535)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1317)
Startups (3562)
United States (13707)
Vaccines (550)
Weight loss (169)
Date
Today (132)
Last 7 days (617)
Last 30 days (3699)
Last 365 days (35797)
2024 (33029)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37142)
Australia (6062)
California (3384)
Canada (1309)
China (255)
Colorado (149)
Connecticut (154)
Europe (79532)
Florida (471)
Georgia (121)
Illinois (347)
Indiana (197)
Kansas (96)
Maryland (583)
Massachusetts (2652)
Michigan (159)
Minnesota (275)
New Jersey (975)
New York (977)
North Carolina (709)
Northern California (1503)
Ohio (139)
Pennsylvania (855)
South America (1091)
Southern California (1317)
Texas (485)
Utah (91)
Washington State (366)
685,922 Results for "amedisys inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amedisys Reports Third Quarter 2024 Financial Results
November 7, 2024
·
24 min read
Business
Amedisys Reports First Quarter 2024 Financial Results
Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.
April 24, 2024
·
19 min read
Business
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.
February 21, 2024
·
26 min read
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing to its care centers nationwide.
February 8, 2024
·
4 min read
Business
Amedisys Reports Second Quarter 2024 Financial Results
July 25, 2024
·
24 min read
BioMidwest
Amedisys Finds Answer Key in Medalogix Pulse
Medalogix and Amedisys announced an expanded partnership with the implementation of Medalogix Pulse for Home Health patients.
December 28, 2023
·
4 min read
Business
Amedisys Reports Third Quarter 2023 Financial Results
Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.
October 24, 2023
·
27 min read
Business
Amedisys Reports Second Quarter 2023 Financial Results
Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.
July 26, 2023
·
26 min read
BioMidwest
Amedisys Celebrates National Quality WeekHeld October 15-21, this Observance Shines a Light on Our Commitment to Quality Care
Amedisys, Inc., a leading provider of home health, hospice and high-acuity care in the home, is proud to celebrate National Quality Week October 15-21, 2023.
October 18, 2023
·
3 min read
Deals
Amedisys Announces Receipt of Unsolicited Proposal From Optum
Amedisys, Inc. announced that on May 26, 2023, the Company received an unsolicited proposal from Optum, a diversified health services company, to acquire all of the outstanding shares of Amedisys’ common stock in an all-cash transaction for $100 per share.
June 5, 2023
·
10 min read
1 of 68,593
Next
